BCM
Bayesian Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,262
| Closed | -$757K | – | 703 |
|
|
2024
Q3 | $757K | Sell |
2,262
-1,000
| -31% | -$335K | 0.09% | 286 |
|
|
2024
Q2 | $891K | Buy |
+3,262
| New | +$891K | 0.1% | 256 |
|
|
2023
Q4 | – | Sell |
-7,568
| Closed | -$2.71M | – | 760 |
|
|
2023
Q3 | $2.71M | Buy |
+7,568
| New | +$2.71M | 0.31% | 87 |
|
|
2020
Q1 | – | Sell |
-3,004
| Closed | -$1.11M | – | 780 |
|
|
2019
Q4 | $1.11M | Sell |
3,004
-3,300
| -52% | -$1.22M | 0.19% | 162 |
|
|
2019
Q3 | $2.1M | Sell |
6,304
-2,000
| -24% | -$666K | 0.4% | 60 |
|
|
2019
Q2 | $2.6M | Buy |
8,304
+4,700
| +130% | +$1.47M | 0.54% | 41 |
|
|
2019
Q1 | $1.1M | Buy |
3,604
+900
| +33% | +$275K | 0.21% | 147 |
|
|
2018
Q4 | $628K | Sell |
2,704
-2,278
| -46% | -$529K | 0.13% | 237 |
|
|
2018
Q3 | $1.56M | Buy |
4,982
+3,000
| +151% | +$939K | 0.26% | 100 |
|
|
2018
Q2 | $572K | Buy |
1,982
+844
| +74% | +$244K | 0.13% | 232 |
|
|
2018
Q1 | $285K | Sell |
1,138
-3,315
| -74% | -$830K | 0.07% | 409 |
|
|
2017
Q4 | $1.06M | Buy |
+4,453
| New | +$1.06M | 0.22% | 158 |
|
|
2017
Q1 | – | Sell |
-3,563
| Closed | -$649K | – | 418 |
|
|
2016
Q4 | $649K | Buy |
+3,563
| New | +$649K | 0.16% | 244 |
|